Bremelanotide acetate is a compound with a cyclic heptapeptide structure. Numerous studies have shown that its receptor molecules play an important role in sexual arousal, reducing appetite, and catalyzing melanin synthesis, so it can be used to treat sexual dysfunction, obesity, and promote melanin production in the skin to protect against UV burns and other related diseases. PT-141 is a drug developed by Palatin Company in the United States to treat sexual dysfunction, which has completed phase III clinical trials, and the results have shown that it is effective in both male and female patients, especially for female frigidity, it is the only effective drug candidate.
Basic information
English name: PT141 Acetate/ Bremelanotide Acetate
Company number: GT-A005
CAS Number: 189691-06-3,1607799-13-2 (Acetate)
Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH (Lactam：Asp2-Lys7)
Molecular formula: C50H68N14O10
Molecular weight: 1025.16
Post time: 2025-08-29